Boosting Health and Life Sciences
The prime minister has unveiled a £200m cash injection for the UK's health and life sciences industry. The funding will be matched by £400m of private investment to allow science companies to expand development plans.
The government intends that this investment will allow companies to raise capital to run clinical trials, employ more industrial scientists and boost manufacturing in the UK.
Boris Johnson said it was part of his vision to have a "vibrant post-Brexit economy fuelled by science and technology".
He said:
"The UK has the best universities in the world and we have a proud history of scientific discovery from penicillin to sequencing the human genome. But too often we let another country commercialise this discovery.
"I want the lifesaving cancer treatments of tomorrow to say 'discovered and made in Britain'. That means allowing enough late stage capital to be mobilised so that these science discoveries do not have to go overseas to be commercialised."
The government intends that this investment will allow companies to raise capital to run clinical trials, employ more industrial scientists and boost manufacturing in the UK.
Boris Johnson said it was part of his vision to have a "vibrant post-Brexit economy fuelled by science and technology".
He said:
"The UK has the best universities in the world and we have a proud history of scientific discovery from penicillin to sequencing the human genome. But too often we let another country commercialise this discovery.
"I want the lifesaving cancer treatments of tomorrow to say 'discovered and made in Britain'. That means allowing enough late stage capital to be mobilised so that these science discoveries do not have to go overseas to be commercialised."
Comments